The News Review:

- Cape Cod Clinical Research Inc. Launches TrialDCS¢
- Altarum Institute buys Maryland-based clinical research support …
- KU and K-State Join Forces in Cancer Research
- ‘Clinical research norms restrictive’
- Medpace Inc. Celebrates the First Year Success at the Medpace …
- Alnylam Pharmaceuticals Inc elects Akshay Vaishnaw as senior vice …
- Speaking the same ‘language’

Cape Cod Clinical Research Inc. Launches TrialDCS¢
SYS-CN Media NJ 
Cape Cod Clinical Research Inc. Launches TrialDCS? | SYS-CN UK.

Altarum Institute buys Maryland-based clinical research support …
MLive.com MI 
KAI Research provides contracted clinical research support services. Altarum employs 350 across five offices nationwide including about 90 at its Ann Arbor headquarters. post-footer img { margin-top: -10px }.

KU and K-State Join Forces in Cancer Research
KCUR M 
The agreement allows eligible scientists at K-State to become adjunct professors at KU. It also gives scientists at both places greater access to each other’s cancer facilities and confidential research. Rob Denell is director of K-State’s Cancer Institute and says the new agreement will bring about more collaborations between the scientists focusing on basic research at K-State and the scientists focusing on clinical research at KU. Denell: “Basically from our point of view what we anticipate is that it’s going to allow our scientists more access to clinical material that it’s going to facilitate having our basic research potentially move in to clinical trials and other kinds of actual applications. ” KU says the agreement marks a big step in its efforts to become a nationally designated Cancer Institute. Funding for health care coverage on KCUR has been provided by the Health Care Foundation of Greater Kansas City. Download recent health stories or subscribe to the.

‘Clinical research norms restrictive’
Economic Times India 
nkar Kanwar the chairman of the hospital shares the company’splans with ET. Has theeconomic slowdown adversely affected the healthcaresector? There is no doubt that the industry should be able toweather the current downturn as healthcare is a basic necessity and thepossibility of delaying healthcare expenditures for longer periods is more orless remote. Ailing health will always require medical attention irrespectiveof the economic conditions. When someone needs cardiac care or let’s saycritical care they do not usually have the leisure to worry about recession ormarket conditions.
Related from Rizzicreations: Auto industry gears up to meet Bharat Stage-IV norms

Medpace Inc. Celebrates the First Year Success at the Medpace …
MSNBC 
ABUT MEDPACEMedpace is a leading global full-service. Medpace hasassembled the industry’s most experienced and therapeutically focused teamto execute at every level of the company’s operations providing completeand seamless drug development services.

Alnylam Pharmaceuticals Inc elects Akshay Vaishnaw as senior vice …
Trading Markets (press release) CA 
He led the pre-clinical and clinicaladvancement of the Alnylam’s pipeline of RNAi therapeutics includingALN-RSV01 for the treatment of RSV infection and ALN-VSP for thetreatment of liver cancers as well as other programmes in the areas ofhypercholesterolemia Huntington’s disease and transthyretin (TTR)amyloidosis. He has also served as a member of Alnylam’s managementteam. Previously Vaishnaw served as senior director of TranslationalMedicine at Biogen Idec and spent seven years with the company. Additionally the company stated that Vaishnaw has published papers inleading scientific journals and has also authored a number of textbookchapters relating to autoimmune disease.

Speaking the same ‘language’
University at Buffalo Reporter NY 
Also located in the Center of Excellence on the Buffalo Niagara Medical Campus is the ntology Research Group which Smith co-directs with Werner Ceusters professor of psychiatry and Louis J. Goldberg dean emeritus of the School of Dental Medicine. For the past four years Smith has been working with the developers of bio-ontologies including the Gene ntology to demonstrate how the lessons learned in philosophy and logic—for example the proper use of definitions and classifications—can lead to improvements that in turn can bring real benefits to biological and clinical research. “The use of ontologies by clinical researchers reflects recognition of the need for common frameworks for integrating data across biological and clinical disciplines” said Smith. “It also reflects increasing efforts by the National Institutes of Health and other bodies to encourage clinical researchers to make their data more easily available to wider groups of researchers. “The new approach to ontology which we pioneered at UB makes it easier to build good quality ontologies in a consistent fashion and to reason with the associated data in a way that is designed to be easily extendible to new diseases and new pathogens” he explained. ther diseases being studied under the ID Consortium established by Smith and Cowell include malaria and other vector-borne diseases tuberculosis infective endocarditis influenza and dengue fever.